miR-629-3p Level Significantly Predicts Prognosis in Glioblastoma Patients Treated with Temozolomide Chemotherapy

E-ISSN： 2212-389x|9|1|9-14

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.9, Iss.1, 2014-04, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 2926-2932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1720-1726

Spandidos Publications

Access to resources Recommend Favorite

Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 675-680

Karger

Access to resources Recommend Favorite

MicroRNA miR‐371a‐3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker

ANDROLOGY, Vol. 3, Iss. 1, 2015-01 ,pp. : 78-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR-142-3p et leucémogenèse

By Lagrange Brice Martin Romain Z. Droin Nathalie Solary Éric Bastie Jean-Noël Delva Laurent

Médecine/sciences, Vol. 29, Iss. 6-7, 2013-07 ,pp. : 574-576

Edp Sciences

Access to resources Recommend Favorite